Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
<b>Background</b>: Histone deacetylase inhibitors (HDACIs) are a relatively new class of potential drugs for treating cancer. <b>Aim</b>: Discovery of new anticancer agents targeting HDAC. <b>Methods</b>: New uracil and thiouracil derivatives panels were designed...
Saved in:
Main Authors: | Omnia R. Elbatrawy (Author), Mohamed Hagras (Author), Moshira A. El Deeb (Author), Fatimah Agili (Author), Maghawry Hegazy (Author), Ahmed A. El-Husseiny (Author), Mahmoud Mohamed Mokhtar (Author), Samy Y. Elkhawaga (Author), Ibrahim H. Eissa (Author), Samar El-Kalyoubi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline-Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors
by: Samar A. El-Kalyoubi, et al.
Published: (2022) -
Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation
by: Mohamed Hagras, et al.
Published: (2021) -
One-Pot Synthesis and Molecular Modeling Studies of New Bioactive Spiro-Oxindoles Based on Uracil Derivatives as SARS-CoV-2 Inhibitors Targeting RNA Polymerase and Spike Glycoprotein
by: Samar A. El-Kalyoubi, et al.
Published: (2022) -
Novel pyrimidine Schiff bases and their selenium-containing nanoparticles as dual inhibitors of CDK1 and tubulin polymerase: design, synthesis, anti-proliferative evaluation, and molecular modelling
by: Samar El-Kalyoubi, et al.
Published: (2023) -
Rational Coformer Selection in the Development of 6-Propyl-2-thiouracil Pharmaceutical Cocrystals
by: Francisco Javier Acebedo-Martínez, et al.
Published: (2023)